Drug Eluting Balloon
September 21-25, 2010
TCT 2010 – Transcatheter Cardiovascular Therapeutics
B. Braun Vascular Systems, booth number 2035
Washington Convenion Center, Washington D.C., USA
www.tctconference.com
In addition, different lectures about Sequent® Please with PACCOCATH® Technology will be held:
The Drug Eluting Stent Summit (Part 2): Next Generation DES, Bioabsorbable Stents and Drug-Eluting Balloons
German Consensus Group Recommendations for DEB Development
Date: Wednesday, September 22, 2010
Time: 2:22 p.m. to 2:37 p.m.
Presenter: Bruno Scheller
The PACCOCATH® (Cotavance And Sequent Please) Paclitaxel DEB Technology and Compressive Review of All Completed and Planned Clinical Trials
Date: Wednesday, September 22, 2010
Time: 2:37 p.m. to 2:52 p.m.
Presenter: Detlef G. Mathey
First Report Investigations I – PERFECT STENT TRIAL
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease
Date: Thursday, September 23, 2010
Time: 12:30 to 12:40 p.m.
Place: Washington Convention Center, Main Arena, Ballrooms ABC, Level 3
Presenter: Jochen Wöhrle
Moderated Discussion: Juan F. Granada
Featured Clinical Research III – PEPCAD-CTO
A prospective Nonradomized Study of Paclitaxel-Eluting Balloons After Bare Metal Stent Placement in Successfully Recanalized Chronic Total Occlusions.
Date: Friday, September 24, 2010
Time: 7:15 p.m. to 7:25 p.m.
Place: Washington Convention Center, Room 143B
Presenter: Gerald S. Werner
Furthermore B. Braun and Medrad organized a breakfast symposium on September 23, 2010.
Time: Breakfast at 6:30 a.m./ Program: 7:00 a.m.-8:00 a.m.
Place: Washington Convention Center, Room 144A
The title is : “What Pre-Clinical and Clinical Results Have Taught Us About the PACCOCATH® Drug-Eluting Balloon Technology: Not all Drug-Eluting Balloons are Created Equal”
Introduction (Moderator: Robert Schwartz)
Standardization of Technology and Testing for Drug Eluting Balloons
Clinical Evidence of the PACCOCATH® Technology – Overview of Coronary Clinical Studies
Speaker: Detlef G. Mathey
Practical Application of the PACCOCATH® Technology – Tips & Tricks
Speaker: Bruno Scheller
PACCOCATH® Technology Development Update – Insights into Safety and Efficacy of Latest Generation Cotavance Drug Eluting Balloon
Speaker: Juan Granada
PACCOCATH® Technology in Peripheral Applications – Prior Experience and Future Directions
Speaker: William Gray
Discussion among the panel and audience!
May 25-28, 2010
EURO PCR – Paris 2010
Paris, France
www.europcr.com
B. Braun and Medrad PCR Satellite Symposium “What Preclinical and Clinical Results have Taught us about the PACCOCATH® Drug Eluting Balloon (DEB) Coating Technology: Not all Drug Eluting Balloons are Created Equal”
Chairman: Eric Eeckhout/Ulrich Speck
Introduction: Development of the DEB Concept
Ulrich Speck (Charité Berlin, Germany)
Biological Concepts and Lessons Learned from the PACCOCATH® Technology in Pre-Clinical Animal Models
Juan Granada (Orangeburg, USA)
Animal Data and Clinical Results of Different Drug Eluting Balloon Systems
Bruno Scheller (Homburg/Saar, Germany)
The PEPCAD Clinical Trial Program
Detlef Mathey (Hamburg, Germany)
Practical Application of the PACCOCATH® Technology – Tricks and Tips
Franz-Xaver Kleber (Potsdam, Germany)
Paccocath® for Treatment of Peripheral Artery Disease
Gunnar Tepe (Tuebingen, Germany)
Future Horizons for the PACCOCATH® Technology
Nicolas Diehm (Bern, Switzerland)
Conclusion and Q&A Session with Panellists
Eric Eeckhout (Lausanne, Switzerland)
The complete panel discussion is available as a webcast containing the original presentations and statements on cardio-sympoisum.org
08.-10 April 2010
76. Jahrestagung der DGC
Mannheim, Deutschland
http://www.dgk.org
Freitag, 9. April 2010 (Saal 19)
Hotline: Studien / Register
(V950) PEPCAD III Studie – randomisierter Vergleich eines DES mit einer Kombination aus DEB und BMS
B. Scheller (Homburg/Saar)
Samstag, 10. April 2010 (Saal 18)
Arbeitsgruppe „Interventionelle Kardiologie“ VIDEO CASE-Sitzung
Interventionelle Innovationen – was ist wirklich ein Fortschritt? (V1243) Video Case Bifurkations-Behandlung: BMS, DES oder DEB?
B. Scheller (Homburg/Saar)
Poster
Clin Res Cardiol 99, Suppl 1, April 2010
P1002 – Paclitaxel-beschichtete SeQuent® Please Ballonkatheter: – „Real Life Scenario“ bei therapierefraktären in-Stent Restenosen
B. Cremers1, Y. P. Clever1, W. von Scheidt2, M. Böhm1, B. Scheller1
Clin Res Cardiol 99, Suppl 1, April 2010
P997 – Patients’risk characteristics as predictors for clinically driven TLR and MACE within an ‘all comer’ DES Registry
M. Leschke1, V. T. Nhan2, V. Palacios3, I. G. Horvath4, C. C. Ling5, V. A. Ivanov6, D. Tresukosol7, P. Avraamides8, M. Waliszewski9, A. Schneider1